Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BostonGene Corporation

< Previous 1 2 Next >
News headline image
BostonGene to Present AI Innovations at BIO 2026
From BostonGene Corporation
Via Business Wire
News headline image
Hokkaido University Leverages BostonGene’s AI-powered Platform to Advance Precision Oncology
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene RNA Transcriptome Profiling Reveals New ADC Targets in Advanced Solid Tumors
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Demonstrates Disease Modeling Platform at JSMO 2026, Advancing AI-Driven Drug Development and Precision Oncology
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Advances AI-Driven Disease Modeling in Oncology in Collaboration with Leading Experts in Cancer Genomics at USCAP 115th Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Named ‘Innovator of the Year’ at Boston Life Sciences Times Vanguard Awards
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Unilever Partner to Apply AI and Multiomics Research to Support Consumer Innovation
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene CEO Andrew Feinberg to Deliver Keynote at Mobile World Congress Barcelona 2026
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics
From BostonGene Corporation
Via Business Wire
News headline image
Independent Multi-Vendor Study Validates BostonGene’s AI for Precision HER2 Scoring
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Collaboration with Ottimo Pharma to Optimize and Accelerate Development of First-in-Class PD-1/VEGFR2 Immuno-Oncology Therapy Using AI
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Sylvester Comprehensive Cancer Center to Showcase Omnimodal AI Clinical Trial Innovations at Association for Molecular Pathology 2025 Annual Meeting & Expo
From BostonGene Corporation
Via Business Wire
News headline image
Study Published in Cell Reports Medicine Showcases BostonGene’s Multimodal AI Solutions to Stratify PD-1 and VEGF Immunotherapy Outcomes in Kidney Cancer
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Showcase its Multimodal AI Platform Advancing Drug Development at the 2025 ASCO® Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BioTech Breakthrough Awards BostonGene With “Cancer Immunology Solution of the Year”
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in Friends of Cancer Research Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in The Festival of Genomics & Biodata 2025
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Drive Value-Based Cancer Care Discussions at the 14th Annual AVBCC Summit and Educational Program
From BostonGene Corporation
Via Business Wire
News headline image
GlobalData Awards BostonGene with Four Clinical Trials Arena Excellence Awards
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in the European Federation of Laboratory Medicine Strategic Conference 2024
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Leading Global Cancer Institutions Announce Nature Publication
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Honored as Gold and Silver Stevie® Award Winner in 2024 Stevie Awards for Technology Excellence
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Mount Sinai to Collaborate on a Prospective Precision Medicine Study of Patients with Multiple Myeloma
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Showcases AI-Powered Multiomics Platform and Advances in Immune System Profiling at 14th World Clinical Biomarkers & CDx Summit
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Publication and Journal Cover Feature in Cancer Cell that Unveils a New Immune System Profiling Platform Stratifying Cancer Patients by Treatment Response
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Recognized as Designated Laboratory for the ComboMATCH Precision Medicine Clinical Trial
From BostonGene Corporation
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.